| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.0034 | 1 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |